DHA Softgel Capsule By Exeltis USA Overview & Drug Interactions

Check For Interactions With DHA Softgel Capsule

Supplement: DHA Softgel Capsule by Exeltis USA

DHA Softgel Capsule Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with DHA Softgel Capsule by Exeltis USA

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with DHA Softgel Capsule. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about DHA Softgel Capsule interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Pregnant and Lactating
Minimum serving Sizes:
1 Softgel Capsule(s)
Maximum serving Sizes:
1 Softgel Capsule(s)
Servings per container 30
UPC/BARCODE 30642-0076-305

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Docosahexaenoic Acid
250 mg
DHA (Docosahexaenoic Acid) --

Other Ingredients:


Label Statments:


Formula
- Indications and usage: Vitafol-OB+DHA is indicated to provide vitamin, mineral, and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.
- Indications and usage: Vitafol-OB+DHA is indicated to provide vitamin, mineral, and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.
- Prenatal Supplement with DHA Natural source DHA
- Vitafol-OB+DHA (Daily Dose)
- Smaller DHA Softgel
Formulation
- Vitafol-OB+DHA does not contain fish, fish oils, fish proteins or fish byproducts.
- Sugar, lactose, gluten and iodine free
Precautions
- Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.
- Contains: Soy.
Suggested/Recommended/Usage/Directions
- Dosage and administration: Before, during and after pregnancy, one caplet and one softgel capsule daily, or as directed by a physician.
- See package insert for full prescribing information
General Statements
- How supplied: Vitafol-OB+DHA is available as a light blue caplet debossed EV0079 and one amber-colored DHA softgel capsule. Available in box of unit-dose pack of 30 (5 child resistant blister cards of 6 caplets and 6 softgel capsules each) (0642-0076-30) and as professional samples (0642-0076-03).
- Unit dose pack
- 0642-0076-30
Storage
- Store at room temperature, approximately 15 Degrees - 30 Degrees C (59 Degrees - 86 Degrees F), avoid excessive heat and moisture.
FDA Disclaimer Statement
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Brand IP Statement(s)
- Copyright 2022 Exeltis USA, Inc. All rights reserved. U.S. Patent No. 7,390,509; 8,617,617 Vitafol is a trademark of Exeltis Healthcare, S.L.
- U.S. Patented
FDA Statement of Identity
- Prenatal Supplement with DHA

Brand Information

See all products by this brand

Distributed by
Name Exeltis USA, Inc.
City Florham Park
State NJ
ZipCode 07932
Phone Number 1-877-324-9349
Web Address www.exeltisUSA.com

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.